Enzo Biochem, Inc. Common Stock ($0.01 Par Value) (NY:ENZ)

0.3138 UNCHANGED

Last Price Updated: 7:00 PM EDT, Apr 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Enzo Biochem, Inc. Common Stock ($0.01 Par Value)

< Previous 1 2 3 4 Next >

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 11, 2023

Via Benzinga

Enzo Biochem Reports Third Quarter Fiscal Year 2023 Financial Results

June 14, 2023

From Enzo Biochem, Inc.

Via GlobeNewswire

Federman & Sherwood Investigates Enzo Biochem for Data Breach

June 02, 2023

From Federman & Sherwood

Via Business Wire

Enzo Biochem Reports Significant Progress towards Completing the Clinical Lab Asset Sale

May 22, 2023

From Enzo Biochem, Inc.

Via GlobeNewswire

Enzo Biochem (NYSE: ENZ) Leading the Way in Friday Trading Based on Percentage Gain

March 17, 2023

Via Investor Brand Network

Why Is Histogen (HSTO) Stock Up 37% Today? ↗

March 17, 2023

Histogen (HSTO) stock is rising higher on Friday after getting a patent for CTS-2090 that protects its products through 2040.

Via InvestorPlace

Enzo Biochem, Inc. Announces Date of Special Meeting of Shareholders

April 24, 2023

From Enzo Biochem, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

April 07, 2023

Via Benzinga

Enzo Biochem Reports Second Quarter Fiscal Year 2023 Financial Results

March 21, 2023

From Enzo Biochem, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 17, 2023

Via Benzinga

Why Is Enzo Biochem (ENZ) Stock Up 72% Today? ↗

March 17, 2023

Enzo Biochem (ENZ) stock is rocketing higher on Friday with heavy trading after the company agreed to an asset sale with Labcorp (LH).

Via InvestorPlace

Why Baidu Shares Are Trading Higher By More Than 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 17, 2023

Gainers Enzo Biochem, Inc. (NYSE: ENZ) gained 86.5% to $2.22 after the company announced it will sell its clinical laboratory to Labcorp.

Via Benzinga

Crude Oil Down 2%; Enzo Biochem Shares Spike Higher ↗

March 17, 2023

U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 300 points on Friday. The Dow traded down 1.07% to 31,899.93 while the NASDAQ fell 0.68% to 11,638.13. The S&P...

Via Benzinga

Why Is Diebold Nixdorf (DBD) Stock Down 42% Today? ↗

March 17, 2023

Diebold Nixdorf (DBD) stock is taking a beating on Friday after the company released its annual shareholder letter for 2022.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 17, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

March 17, 2023

The biggest pre-market stock movers for Friday are ready to go as we dive into the latest news for investors this morning!

Via InvestorPlace

Why Sarepta Therapeutics Shares Are Trading Lower By Around 19%; Here Are 20 Stocks Moving Premarket ↗

March 17, 2023

Gainers Enzo Biochem, Inc. (NYSE: ENZ) shares rose 89.9% to $2.26 in pre-market trading after the company announced it will sell its clinical laboratory to Labcorp.

Via Benzinga

Why Enzo Biochem Stock Is Skyrocketing After Hours ↗

March 16, 2023

Enzo Biochem Inc (NYSE: ENZ) shares are soaring in extended trading Thursday after the company agreed to sell its clinical lab to Laboratory Corporation Of America

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

March 16, 2023

Via Benzinga

Enzo Biochem Agrees to Sell Clinical Laboratory to Labcorp

March 16, 2023

From Enzo Biochem, Inc.

Via GlobeNewswire

Tenaya Therapeutics, Clear Channel Outdoor And These 2 Penny Stocks Insiders Are Aggressively Buying ↗

January 20, 2023

The Dow Jones closed lower for the third straight session on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and...

Via Benzinga

Myomo, Enzo Biochem And These 2 Stocks Under $2 Insiders Are Aggressively Buying ↗

January 19, 2023

The Dow Jones closed lower by more than 600 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Nasdaq Rises 100 Points; Gold Gains Over 1% ↗

December 13, 2022

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining 100 points on Tuesday

Via Benzinga

Dow Turns Lower; Crude Oil Rises Sharply ↗

December 13, 2022

U.S. stocks pared gains midway through trading, with the Dow Jones turning lower on Tuesday

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

December 13, 2022

On Tuesday, 49 companies hit new 52-week lows.

Via Benzinga

Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session ↗

December 13, 2022

Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.

Via Benzinga

Earnings Scheduled For December 12, 2022 ↗

December 12, 2022

Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is projected to report earnings for its second quarter.

Via Benzinga

Enzo Biochem, Inc. to Report First Quarter Fiscal 2023 Financial Results and Business Update on Monday, December 12th

December 07, 2022

From Enzo Biochem, Inc.

Via GlobeNewswire

Enzo Biochem, Inc. Announces Date of Annual Shareholders’ Meeting

November 08, 2022

From Enzo Biochem, Inc.

Via GlobeNewswire

Farmer Bros. Co. Announces Board Refresh and Cooperation Agreement with Stockholders JCP Investment Management and 22NW

October 31, 2022

From Farmer Bros. Co.

Via GlobeNewswire

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.